For instance, miR-30c suppressed hepatic lipid synthesis by targeting lysophosphatidyl glycerol acyltransferase 1 (Lpgat1), inhibited VLDL production via suppression of microsomal triglyceride transfer protein (Mtp), and improved hyperlipidemia and atherosclerosis in Apoe−/− mice [29]. Here, MTTP is linked to hyperlipidemia.